Medline (MDLN) vs Stryker (SYK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Stryker is the larger company by market cap ($106.24 billion vs $48.09 billion), about 2.2 times the size. On valuation, Stryker trades at a lower forward P/E (16.6x vs 22.7x for Medline). Stryker pays a dividend yielding 1.26%, while Medline does not currently pay one.
Stryker converts more of its revenue into profit, with a net margin of 12.9% versus 4.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDLN | SYK |
|---|---|---|
| Share price | $35.74 | $276.97 |
| Market cap | $48.09B | $106.24B |
| 1-day change | +0.82% | +0.57% |
| YTD return | -15.60% | -21.20% |
| 1-year return | — | -26.20% |
| 5-year return | — | +4.00% |
| P/E ratio (TTM) | 89.35 | 28.70 |
| Forward P/E | 22.67 | 16.59 |
| EPS (TTM) | $0.40 | $9.65 |
| Dividend yield | 0.00% | 1.26% |
| Annual dividend | $0.00 | $3.48 |
| Revenue (latest FY) | $28.43B | $25.12B |
| Revenue growth (YoY) | — | +11.16% |
| Net income (latest FY) | $1.16B | $3.25B |
| Gross margin | 26.44% | 63.96% |
| Operating margin | 7.78% | 19.47% |
| Net margin | 4.08% | 12.92% |
| 52-week high | $50.88 | $392.55 |
| 52-week low | $31.49 | $267.00 |
| Distance from 52-week high | -29.75% | -29.44% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +24.51% | +32.20% |
| Average volume | 7.66M | 2.64M |
| Shares outstanding | 877.35M | 383.57M |
| Employees | 45,000 | 56,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Stryker is about 2.2 times larger than Medline by market value ($106.24B vs $48.09B).
- Medline trades at a higher earnings multiple (89.4x vs 28.7x trailing P/E).
- Stryker offers a meaningfully higher dividend yield (1.26% vs 0.00%).
- Stryker is more profitable, keeping 12.9 cents of every revenue dollar as net income versus 4.1 cents for Medline.
About Medline
MDLN stock →Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally.
Health Care · Medical/Dental Instruments · 45,000 employees
About Stryker
SYK stock →Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
Health Care · Medical/Dental Instruments · 56,000 employees
MDLN vs SYK FAQ
Which is bigger, Medline or Stryker?
Stryker (SYK) is larger, with a market capitalization of $106.24B compared with $48.09B for Medline (MDLN).
Which has the lower P/E ratio, MDLN or SYK?
SYK has the lower trailing P/E at 28.7, versus 89.4 for MDLN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Medline or Stryker?
Stryker pays a dividend yielding 1.26%, while Medline does not currently pay a regular dividend.
Are Medline and Stryker in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.